Those who dream big only have the capability to achieve big.
We dreamt of making our mother earth free from diseases and in this path we finally innovated Receptol.

From all of us at Biomix, myself, with the blessings of Almighty we wish you and your extended families, Season's greetings, Merry Christmas and a Prosperous 2024!



  Business opportunity for collaboration on a globally patented immune enhancer & weight loss drug Receptol® for prevention of all Pandemics & natural weight loss with no side effects unlike new mRNA vaccines & weight loss drugs in market.

Global pandemics like walking pneumonia, diabetes, COVID-19, Bird Flu, Swine Flu, HIV, and other communicable DiseaseX & chronic immunity disorders in cancer, CNS, and unmet medical needs, present a significant challenge to human health.

People with lowered immunity are at higher risk of getting these infections with increased morbidity. The recent and ongoing long COVID-19 infections made evident that these illnesses pose a significant burden on societal health and strain the healthcare systems across the world.

We have patented a new therapy that strengthens a person’s innate immune function & natural weight loss and therefore is an addition to the therapeutic armamentarium in managing such illness as SARS Covid, AIDS , immune oncology and immune related disorders including URTI & obesity with significant unmet medical needs such as RA, SLE, Cancer and infectious diseases, cure for AIDS, long COVID and natural weight loss for which US FDA & EMA emergency approval are being pursued.

We are pleased to offer you an opportunity to collaborate on the commercialisation of this new therapy across the world and set up world class 1st Nano-biotech manufacturing facilities in North & South America, Europe, & Asia PAC.

Biomix Network Ltd. was incorporated in November 1996 and registered in India and Biomix Network Inc, was registered as Delaware C-Corp in 2004 in US (Delaware).

The founder directors of the company include the Nobel prize winner, Late Dr. George Wald (President Harvard University & Medical School), the discoverer of vit-A and two-times recipient of the Nobel prize; Joseph Weizenbaum, the inventor of 1st AI Robot, Dr Robert Mah, B Tech, M Tech, PhD ( Stanford University) Former NASA Director and Stanford Almuni along with Dr. Pawan Saharan, Biomix Founder and Inventor of Receptol®.

We have previously collaborated with Indian Council of Medical Research (ICMR), National AIDS Control Organization of India (WHO India), and the Department of Science & Technology (DST), Govt of India, New Delhi that funded our new drug discovery, R&D, Global clinical trial, and world’s 1st Nano-biotech plant of Receptol®. (Spotlight US Journal Interview with Dr. Saharan)

After 21 years of R&D with help of eminent group of scientists Receptol® Oral spray was developed, enabling people to build body’s own immune system naturally, to prevent and treat 58 unmet medical needs. This product is manufactured through state-of-the-art US patented technology and holds Global therapeutic product patents.

Receptol® oral spray can be an answer to prevent & treat All Immunity disorders & obesity without any side effects as per the recent publication in progress with New England Journal of Medicine, Science & Nature.

The mammalian colostrum derived nano peptides for broad-spectrum viral and recurrent infections along with 58 approved indications by US PTO with a method of isolation thereof, Patented product with U.S. Patent No. 9,249,188 on February 02, 2016 & US product Patent US 8,518,454 B2; South Africa Patent # 2011/04687; European Patent Application #. 09827010.1. Patent Information.

Clinical data : Early phase studies were conducted in Africa in patients with HIV infection and at Ohio US. (HIV Study Reports: Africa1, Africa2, India1, India2, USA - Ohio). Phase-III accelerated clinical trial was conducted in India to study the effect of Receptol® in patients with HIV / AIDS as a model for totally Immune compromised patients.

(CTRI Registration No.: CTRI/2012/08/002931). In summary, there was significant reduction in viral load & resolution of clinical symptoms of diarrhea, fever, cough, and chronic fatigue syndrome; there was a significant increase in CD4 count accompanied by a significant increase in body weight. No deaths or any adverse safety signal was reported (Study Report).

The design of the clinical study as a stand-alone monotherapy was based on advice from ethics committees and scientific experts to use the model of a disease as a surrogate for significantly immuno-compromised patients. After the clinical study, and 13 years of regular follow-up of patients, No mortality was reported.

Receptol® a new generation therapeutic drug and vaccine is derived from Bovine Colostrum’s Proline-rich Polypeptides and RADHA (108) Nanopeptide extract produced through a patented technology is a highly effective and safe drug for patients with reduced immune functions. While patents have been obtained for use in 58 indications.

Global Medical community believe the greatest value of the drug is as an immunity enhancer for immune illnesses with significant unmet needs e.g. All Immunity disorder like Cancer, AIDS, Long Covid,Insulin dependent Obesity, Alzheimer, Parkinson, Dementia, Asthma, RA, SLE, Sjogren’s Syndrome endometriosis, Chrinic Fatigue Syndrome. Many of these and other Patented indications are of special interest to your company.

Global clinical efficacy and safety data on Receptol reflect, it is well tolerated with no adverse effects.

Moreover, growth factors contained in colostrum, particularly insulin-like growth factor 1 (IGF-1), play a central role in controlling metabolism. IGF-1 is involved in regulating cell growth and repair and impact on our body's overall energy consumption.

The relationship between colostrum and weight loss is multidimensional & Our metabolism influences how many calories our body burns and is therefore crucial for our weight and, as a result, for losing weight. By increasing adiponectin production, our cell to cell communicator Nano peptides from mammalian colostrum can help optimize fat metabolism and improve insulin sensitivity. This can have positive effects on weight loss, as efficient fat metabolism and better insulin sensitivity help the body use fat reserves more effectively.

Another important component of weight loss is reducing inflammation in the body that immunoglobulins and other anti-inflammatory substances in our Product help reduce inflammation.

All of these factors collectively contribute to stimulating metabolism and supporting weight loss without any side effect.

IPSOS, USA & IRMA, India global market research org conducted in US, UK & India pegged potential sale of our block buster new drug at US$13 billion out of which US accounted for US$5.6bn.

      EXECUTIVE SUMMARYOVERVIEW



      OVERVIEW

Global Health challenges like pandemics (COVID, walking pneumonia, DiseaseX, Long COVID), new pandemics, environmental and war connected health issues have impacted lives and lively hoods, resulting in many trillion dollars in financial losses.

Dr. Pawan Saharan created the first truly Nano-Bio-IT Helix via inventing Globally Patented Colostrum based Nano-Peptides for AIDS therapy : RECEPTOL® ( Receptol® Product Information, MOA and pre-clinical info) along with reusable micro-chip diagnostics Lab on Chip and AI based Patented Virtual Specialty Hospital (AI Knowledge Acquisition Tool “AIKAT”).

These three inventions deliver “Health for All” and address Pandemics, Environment, and Prevention holistically, with 58 indications per US Patents and 108 per UK, EU, and India patents.

Our mission of “Health for ALL” was realized with the invention of RECEPTOL® and is the world’s 1st Immunity Drug to prevent and treat AIDS, Swine Flu, COVID19, Future Pandemics, all viral infections, & other immunity problems via Broad Spectrum Antiviral.

With worldwide Pandemics, we can help 8+ billion worldwide citizens based on common mode of action after 18 years of R&D globally involving 25,301 human subjects.

Late Dr. Abdul Kalam, former President of India, nominated Dr. Saharan for India’s new drug discovery with a funding of INR 120MM (then US$3M) by Dept of Science & technology, Govt. of India.

RECEPTOL® Global Market Research by IPSOS, USA and IRMA, Gujrat India, suggested 1 out of 3 citizens globally would use the product both as a preventive and treatment for all communicable / immune deficiency disorders in the next 5 years with an estimated market cap of US$ 15 billion >= $25B now. This drug is pushing the boundaries of science, accelerating innovation, creating a paradigm shift in Healthcare, Pharma, & Wellness industry.

Our clinically proven, broad spectrum, anti-viral immunomodulator is globally tested with 100% efficacy & safety for 12 years on 25000+ humans.

The product is patented and consists of a new molecule of submicroscopic nonapeptides which have been isolated from bovine colostrum via patented Ultra Nano filtration Technology for the first time.

Hospitals on Chip is an AI based automated, integrated system and platform which helps in managing total health care services including drug discovery and clinical trials in a cost effective and timely manner. This Patented Universal Virtual Hospital and Health Portal provides services like the world’s largest General Hospital in Boston, tele & emergency medicine, CROs, and drug discovery and diagnostics driven by AIKAT (Artificial Intelligence Knowledge Acquisition Tools). This enables last mile delivery to a Global population of 8+ Billion and furthers “Health for All”.

Lab on Chip is a mass screening device to detect virus, bacteria, pollutants and biological/ nuclear warfare impact on humans and livestock. The invention is an apparatus which detects the biological state in any given sample using biomarkers and can be a perfect tool in any worldwide pandemic or war setting that may be exposed to bio, chemical, and/or nuclear weapons.

      STRATEGY

Biomix will manufacture the Product in the USA, India, Australia for captive consumption and export to South America, UK, EU, SE Asia, and RUSSIA, for prevention pandemics, unmet medical needs like cancer and diabetes, dementia, and other neural disorder immunity booster treatment.



      MARKET PROBLEMS

Global pandemics like walking neumonia, COVID-19, Bird Flu, Swine Flu, HIV, chronic immunity disorders, and unmet medical needs have left people with weaker immunity, and they present a significant challenge to human health.



      SOLUTION

We have patented a new therapy that strengthens a person’s innate immune function and therefore is an addition to the therapeutic armamentarium in managing such illness as immune oncology and immune related disorders with significant unmet medical needs such as RA, SLE, Cancer and infectious diseases, including cure for AIDS and long COVID symptoms for which US FDA emergency approval is being pursued.



      OPPORTUNITY

We propose to use 21st Century Nanotechnology Innovation in improving health and wellbeing of 8 billion people by marketing & distribution of 8 different formulations viz. oral gargle, MMS, powder & liquid sachets.

There is an opportunity for family funds via legacy projects, 10% quarterly dividends or 15% preferred shareholding along with exit via Nasdaq, LSE & Bombay Stock Exchange listings.

Projected revenue US$1.45 Billion globally with PAT EBITDA US$566M, based on real time market research conducted by Glaxo and IPSOS USA on 800 families from India, UK, & USA with ITP score of 97-100% for two concepts that respondents liked and were ready to pay for our Product, both on standalone basis & as an additive.

Today’s projections after Long COVID, new pandemics, environmental and war connected health challenges upscale the revenues estimates, as per the RECEPTOL® roadmap.

Potential Revenues: USA: Year 1: USD 1 Billion Year 5: USD >05 Billion
Worldwide: Year 5: USD 7 Billion Year 5: USD >25 Billion

Published-Ref : https://patents.google.com/patent/US9249188B2/en.http://medicaltraveltoday.com/spotlight-interview-pawan-saharan-founder-ceo-biomix-network-inc/ - Patent Information





      Receptol Oral Spray for Corona Virus Treatment and Prevention

Natural Solution to Global Health Problems Created by Covid-19 Pandemic Dr Pawan Saharan, MS, PhD & Post Doc (WVU/Stanford) drpawan@biomix.in, www.biomix.in

Problem Global pandemics like Wuhan COVID-19, Bird Flu, Swine Flu, HIV; communicable diseases & chronic immunity disorders. People with weak immunity are at higher risk of getting these infections with increased morbidity.

Solution Our product made from mother’s 1st milk /bovine colostrum has nano informational peptides that help people lead longer & healthier lives by naturally building the body’s own immune system, aiding in prevention & cure of all communicable & immunity diseases along with sustainable malnutrition eradication for bottom of the pyramid segment globally.

The biggest thing in today’s healthcare is the smallest Nano peptides of REEPTOL capable of preventing global pandemics

Innovation Journey – After 18 years of research, we have successfully isolated Nano peptides from bovine colostrum and conducted global clinical studies on subjects suffering from AIDS, Swine Flue & other communicable & Immunity diseases.

RECEPTOL® manufactured by Biomix was discovered by Dr. Pawan Saharan, MS, Ph.D. WVU, Stanford with eminent group of scientists including 2 times Nobel laureate Prof. George Wald from Harvard & Prof. Joseph Weizenbaum, MIT Founder Directors with 18 years of research and development with funding by the Department of Science & Technology, GoI.

Product - RECEPTOL®, made from Colostrum Nano-peptides helps people lead longer & healthier lives by building the body’s immune system, thus aiding in prevention and cure for all communicable & Immunity diseases: Coronavirus, AIDS, Swine Flu, RA, Allergy etc.

Receptol®️ showed great effectiveness in treatment of retrovirus such as HIV, Swine Flu and SARS like conditions caused by Coronavirus. An accelerated, prospective Phase III global efficacy and safety studies for Receptol®️ Monotherapy was conducted for HIV Positive patients with 10 years follow up showed significant resolution of all symptoms within 3 weeks including consistent week after week weight gain and pharmacological effects with low to undetectable Viral Load and increased Absolute CD4 Counts.

Active Ingredients (API) - Active Ingredients consist of Patented Nano-Informational Peptides extracted from mammalian/ bovine colostrum via Ultra Nano filtration Technology having sequence id 1-8 & Proline Rich Poly Peptides (PRPs). As a natural product, Radha-108 Nanopeptides have no side effects which can be taken safely by all age groups and are not species specific.

Mode of Action - Receptol® gets absorbed in the blood through the buccal mucosa and crosses the Blood-Brain-Barrier. It stimulates maturation of immature thymocytes into either helper or suppressor T cells. It stimulates secretion of Tumour Necrosis Factor & cytokines IL-1 to IL-11, INF-a, INF-y. Activates Natural Killer (NK) Cells, cytotoxic cells of the innate immune system by 5 times.

Receptol®️ oral spray can be an answer to prevent & treat current epidemic of 2019-nCoV as its Mode of Action is similar to that of AIDS for which global studies with 10 years follow were done. Receptol®️’s nano-peptide will not only dock on S glycoprotein receptor on the cell surface to mitigate cell fusion though competitive inhibition, closing doors and windows for all viral entry but will also stimulate the maturation of immature thymocytes into helper & suppresser T cells. T helper cells will help produce antibodies against 2019nCoA.

Suppressor T cells, on the other hand, deactivate other lymphocytes after an infection has been cleared to avoid damage to healthy tissues. Receptol®️ will help to produce memory T cells, in order to expedite the production of antibodies for future infection in all human hosts like a vaccine.

Mode of Action of Receptol drastically differs from other treatments/vaccines in pipeline (current products from Gilead, Astra Zeneca, Eli Lilly, Pfizer Merck) since it blocks entry of all viruses & augments immunomodulation in unique patterns. RECEPTOL® exposes the patient's immune system to the memory of a health threat, whether foreign or native, and the knowledge of how to best respond to protect itself via building body's own immune system naturally like a new born baby is protected with mother's milk.

Recent publication in the American Journal of Biotechnology & Immunology, which can be accessed. Publications in New England Journal of Medicine, Lancet, Science & Nature are in progress.

Article from US media to Covid prevention via building body’s own immune system naturally and revert back asap as how we can work together to save the humanity in this pandemic that has devastated global and Indian economy. http://medicaltraveltoday.com/spotlight-interview-pawan-saharan-founder-ceo-biomix-network-inc/

https://www.biomix.in/images/european-biosimilars-congress-2016-flyer.pdf

Government recognition: Health Minister of India released a Book on RECEPTOL- The Next Wonder Drug Creating a Paradigm shift from prevention to treatment providing health for All.

Ministry of Science & Technology & Ministry of Health funded for setting up the pilot manufacturing facility to provide health for all via clinically proven prevention for all communicable diseases.

Indications -Treatment of URTI, Allergy + Asthma, HIV+TB & associated recurrent infections. Immunity enhancer for prevention of Communicable disease like Covid, Swine Flu, Influenza, Chronic Fatigue Syndrome.

USP- Innovative with common Mode of Action for all URTI & viral infections, affordable, Globally Patented, broad spectrum Anti viral, immuno-modulator, easy to administer, 100% Efficacy with no side effects, can be consumed by all age groups and has no age or sex barriers.

Global Patents - US Product Patent # 9,249,188, Canadian, European, Indian, South African & Singapore for 58 diseases. The US and global product patent: https://patents.google.com/patent/US9249188B2/en.

Global Clinical Studies – RECEPTOL® clinical trials & their meta analysis on 25,301 subjects including healthy population as vaccine, can be accessed https://www.biomix.in/clinical-dossier.html#1

National AIDS Control Organization, Ministry of Health & Family Welfare, GoI, via its 07/05/2014 notification by Secretary Dr VK Subburaj, IAS informed that department of AIDS Control has decided to use Receptol from June 2014 for select patient population under Operational Study Program as Natural Immunity Booster.

Hospitals on Chip is an AI based automated, integrated system and platform which helps in managing total health care services including drug discovery and clinical trials in a cost effective and timely manner. This Universal Virtual, Hospital Patented, Health Portal provides services similar to the world’s largest General Hospital in Boston, tele & emergency medicine, CROs, and drug discovery and diagnostics driven by AIKAT (artificial intelligence based knowledge acquisition tools.)

Lab on Chip is a Mass screening device to detect virus, bacteria, pollutants and biological/ nuclear warfare impact on humans and livestock. The invention is an apparatus which detects the biological state in any given sample using biomarkers and can be perfect tool in current Pandemic scenario caused by viral, nuclear, biological & chemical warfares and environmental pollutants

Published Ref:

https://patents.google.com/patent/US9249188B2/en.

http://medicaltraveltoday.com/spotlight-interview-pawan-saharan-founder-ceo-biomix-network-inc/

https://escientificpublishers.com/receptol-oral-spray-shield-for-coronavirus-proposed-treatment-prevention-as-demonstrated-in-aids-JBI-02-0007


 




 Vision

Health for all, via affordable & effective healthcare for the world

 Mission

Develop & manufacture cost effective safe natural product for prevention & treatment of life threatening diseases & immune disorders.

 Innovation

Our health is directly influenced by our immune system. A balanced and healthy immune system is of utmost importance for our body's ability to defend against infections. WHO proclaimed “It is our ability to create a healthy immune system that represents the greatest potential for gains in human Therefore, creating a healthy immune system via Mother’s 1st Milk: Colostrum & its derivatives harnesses maximum benefit towards human health”




"Receptol is the perfect blend of Ayurvedic and modern day science. Like Ayurvedas, Receptol itself provides holistic healthcare solution. Since this innovative product is prepared from 'Piyusha' (Colostrum), mothers first milk, it provides immunity for life. The roots of our product lie in the ancient science of Ayurvedas."



Receptol - An Answer to Covid -19 with 46 references.
»
»
»
»




News & Events
»
»
Over 3 million people in India suffer from HIV & TB
»
We had supplied Receptol at Mumbai International Airport during Swine Flu Pandemic during 2009 - 2010 under the MIAL agreement.
»
Receptol was also kept at Falguni Pathak's Dandia show in Mumbai, to Prevent Swine Flu from Spreding
»
WHO & ProMED reported clusters of undiagnosed pneumonia in children in northern China due to Immunity Gap. WHO said multiple viruses — influenza, respiratory syncytial virus or RSV, and adenoviruses — as well as mycoplasma pneumoniae, one of the bacterial causes of pneumonia, have been circulating in China for weeks, or in the case of mycoplasma pneumoniae, months causing disease burden by multiple times which can be prevented with Receptol® per details below.

More












Copyright © BIOMIX NETWORK LTD

>>>>>>>